This guidance is intended to help vaccination providers in the administration of Pfizer-BioNTech (COMIRNATY) COVID-19 Vaccine.

This training module will be continually reviewed and updated based on the evolving epidemiology of COVID-19 as well as when new information is available about Pfizer-BioNTech (COMIRNATY) COVID-19 Vaccine.

Healthcare professionals who administer vaccines should also consult guidance from the vaccine manufacturer and state, local, tribal, and territorial health officials.



Page last reviewed: July 13, 2022